News Releases
This section contains information and press releases about Boston Scientific. Press releases are listed in chronological order and archived by year. Information should be considered accurate as of the date prepared. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Boston Scientific is not obligated to update the press releases and information contained in this section of the website.
Click here to access archived Guidant press releases.
Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011 / 2010 / 2009 / 2008 / 2007 / 2006 / 2005 / 2004
2016 Archives
Dec 30, 2016 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 35th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017 in San Francisco. Mike Mahoney, chairman and... |
|
Dec 13, 2016 Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of certain manufacturing assets and capabilities of the Neovasc, Inc., (NASDAQ: NVCN) (TSX: NVC) advanced... |
|
![]() |
Dec 5, 2016 Third consecutive “Best Places to Work for LGBT Equality” award MARLBOROUGH, Mass., December 5, 2016 — Boston Scientific (NYSE: BSX) has been recognized for the third consecutive year as a “Best Place to Work” by the Human Rights Campaign Foundation. The... |
‒ $75M transaction enhances manufacturing expertise in structural heart Boston Scientific Corporation (NYSE: BSX) today announced a definitive agreement to acquire certain manufacturing assets and capabilities of the Neovasc, Inc., (NASDAQ: NVCN) (TSX: NVC) advanced... |
|
Nov 23, 2016 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Citi 2016 Global Healthcare Conference on December 7 in New York City. Dan Brennan, executive vice president & chief... |
|
![]() |
Nov 22, 2016 Acquisition Expands Endoscopy Portfolio Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of EndoChoice Holdings, Inc. (NYSE: GI). With the completion of the acquisition, EndoChoice will become part... |
Boston Scientific today announced that its Cork, Ireland manufacturing facility has received the 2016 Shingo Prize for Excellence in Manufacturing from the Shingo Institute, part of the Jon M.... |
|
Nov 16, 2016 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 28th Annual Piper Jaffray Healthcare Conference on November 29 in New York City. Jeff Mirviss, senior vice president &... |
|
Nov 16, 2016 Late-Breaking Trial Data Presented at AHA Scientific Sessions Demonstrate Success of Alert to Predict Worsening Heart Failure Boston Scientific (NYSE: BSX) today announced results from the first clinical trial evaluating the performance of the HeartLogic™ Heart Failure Diagnostic Service to predict impending heart... |
|
Nov 15, 2016 Acquisition Advances Treatment Options for Women with Uterine Polyps Boston Scientific (NYSE: BSX) has acquired the gynecology and urology portfolio of Distal Access, LLC, a Salt Lake City based company that designs minimally invasive medical devices. The portfolio... |
|
Nov 8, 2016 Kidney Stone Retrieval Device Enables Physicians to Release and Capture Kidney Stones of Multiple Sizes MARLBOROUGH, Mass., (Nov. 8, 2016) – Boston Scientific Corporation (NYSE: BSX) today announced the U.S. and European launch of the Dakota™ Nitinol Stone Retrieval Device with OpenSure™... |
|
Nov 4, 2016 Boston Scientific Corporation (NYSE: BSX) today announced that its wholly owned merger subsidiary, Falcon Merger Corp., has extended its previously announced tender offer for all shares of... |
|
Nov 3, 2016 Technology to Improve Management of Gastrointestinal Diseases Boston Scientific (NYSE: BSX) today announced the acquisition of the LumenR™ Tissue Retractor System from LumenR LLC, a privately held Newark, California based company. The LumenR Tissue... |
|
Nov 2, 2016 Late-Breaking Trial Data Presented at TCT Scientific Sessions and Simultaneously Published in the Journal of the American College of Cardiology Boston Scientific (NYSE: BSX) announced initial U.S. commercial performance results of the WATCHMAN™ Left Atrial Appendage Closure (LAAC) Device today during a late-breaking clinical trial... |
|
Nov 1, 2016 The PLATINUM Diversity Study Provides Much Needed Data about Women and Minority Patients, Who are Under-represented in Cardiology Clinical Trials As part of the commitment to support health equity for all patients, Boston Scientific Corporation (NYSE: BSX) sponsored the PLATINUM Diversity study to evaluate the clinical outcomes of the... |
|
Oct 27, 2016 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Stifel 2016 Healthcare Conference on November 15 in New York City. Dan Brennan, executive vice president & chief... |
|
Boston Scientific Corporation (NYSE: BSX) generated sales of $2.105 billion during the third quarter ended September 30, 2016, compared to the company's guidance range for the quarter of $2.035 to... |
|
Oct 25, 2016 Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the 25th Annual Credit Suisse Healthcare Conference on November 7, in Scottsdale, Arizona. Joe Fitzgerald, executive vice... |
|
Oct 24, 2016 Boston Scientific (NYSE: BSX) today announced key data which will be presented at the 28th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular... |
|
![]() |
Oct 17, 2016 Launch of Hemostasis Clip Advances Innovation within the Field of Endoscopy Boston Scientific Corporation (NYSE: BSX) today announced the launch of the Resolution 360™ Clip, a novel technology designed to improve hemostatic clipping by providing physicians controlled... |
![]() |
Oct 13, 2016 Second Boston Scientific Connected Patient Challenge focuses on digital health Marlborough, Mass. October 13, 2016) -- Boston Scientific Corporation (NYSE: BSX) today announced a worldwide call for submissions to the second annual Boston Scientific Connected Patient... |
Boston Scientific Corporation (NYSE: BSX) announced today that Professor Ian Meredith AM will join the company as executive vice president and global chief medical officer in January 2017. In his... |
|
Oct 7, 2016 Boston Scientific Corporation (NYSE: BSX) today announced that its wholly owned merger subsidiary, Falcon Merger Corp., has launched its previously announced tender offer for all shares of... |
|
Oct 3, 2016 Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the third quarter ended September 30, 2016 on Wednesday, October... |
|
![]() |
Sep 27, 2016 Acquisition Will Expand Endoscopy Gastroenterology Portfolio
Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific has agreed to acquire... |
1-25 26-50 51-68 | |